RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $637,470 | -33.8% | 75,799 | -1.1% | 0.00% | – |
| Q2 2023 | $962,699 | -22.1% | 76,648 | +2.1% | 0.00% | – |
| Q1 2023 | $1,236,238 | +32.7% | 75,060 | +20.4% | 0.00% | – |
| Q4 2022 | $931,270 | -34.1% | 62,334 | -1.4% | 0.00% | -100.0% |
| Q3 2022 | $1,414,000 | +39.3% | 63,217 | +4.4% | 0.00% | – |
| Q2 2022 | $1,015,000 | -33.6% | 60,577 | +18.7% | 0.00% | – |
| Q1 2022 | $1,528,000 | -1.8% | 51,050 | +0.8% | 0.00% | – |
| Q4 2021 | $1,556,000 | +24.8% | 50,664 | +28.1% | 0.00% | – |
| Q3 2021 | $1,247,000 | +2.6% | 39,543 | +19.0% | 0.00% | – |
| Q2 2021 | $1,215,000 | +36.1% | 33,221 | +28.6% | 0.00% | – |
| Q1 2021 | $893,000 | +57.2% | 25,828 | +88.9% | 0.00% | – |
| Q4 2020 | $568,000 | -64.1% | 13,671 | -63.2% | 0.00% | -100.0% |
| Q3 2020 | $1,583,000 | – | 37,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |